Latest News

Use of tPA for ischemic stroke nearly doubled from 2003 to 2011

Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011. A research team reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  • Targeting the brain to treat obesity

  • Early warning sign for babies at risk of autism: Early joint attention predicts later autism symptoms

  • Creating sustainable STEM teacher programs

  • Klotho: neuroprotective against Alzheimer's disease

  • Cell therapy for multiple sclerosis patients: Closer than ever?

  • Computerized ADHD testing

  • Charter schools nationwide more cost-effective, produce greater ROI

  • 'Quack' child psychology practices identified by study

  •